uniQure NV (NASDAQ:QURE)‘s stock had its “buy” rating restated by Cowen and Company in a research report issued on Thursday.
The analysts wrote, “Today, QURE presented additional extension data from the ongoing Ph1/2 trial of.””
QURE has been the topic of a number of other reports. Leerink Swann reissued a “buy” rating and set a $27.00 price target (down from $48.00) on shares of uniQure NV in a report on Wednesday, April 13th. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $26.00 price objective on shares of uniQure NV in a report on Tuesday, April 5th. Chardan Capital reaffirmed a “buy” rating on shares of uniQure NV in a report on Monday, July 18th. Jefferies Group reaffirmed a “buy” rating on shares of uniQure NV in a report on Wednesday, April 6th. Finally, Oppenheimer Holdings Inc. reaffirmed a “buy” rating on shares of uniQure NV in a report on Tuesday, May 31st. One investment analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $30.80.
uniQure NV (NASDAQ:QURE) last announced its quarterly earnings results on Tuesday, May 31st. The company reported ($0.93) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.82) by $0.10. Analysts forecast that uniQure NV will post ($3.44) EPS for the current fiscal year.
Other large investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its stake in uniQure NV by 3.1% in the first quarter. JPMorgan Chase & Co. now owns 8,414 shares of the company’s stock valued at $100,000 after buying an additional 250 shares during the last quarter. Fox Run Management L.L.C. purchased a new stake in uniQure NV during the second quarter valued at about $122,000. Acadian Asset Management LLC purchased a new stake in uniQure NV during the second quarter valued at about $804,000. Landscape Capital Management L.L.C. boosted its stake in uniQure NV by 304.2% in the first quarter. Landscape Capital Management L.L.C. now owns 154,100 shares of the company’s stock valued at $1,831,000 after buying an additional 115,975 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in uniQure NV by 95.6% in the first quarter. Renaissance Technologies LLC now owns 205,800 shares of the company’s stock valued at $2,445,000 after buying an additional 100,600 shares during the last quarter.
Uniqure NV is a pharmaceutical company based in the Netherlands. It is primarily engaged in the field of gene therapy for orphan diseases. The Company is focused on patients suffering from genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.
